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Abstract
Background: Groups of microcalcifications are the most frequent recognized features of ductal carcinoma on mammograms. How-
ever, heterogeneity (in size, morphology and density) and number of microcalcification groups as well as presence of accompanied
soft-tissue density are not included in breast imaging reporting and data system (BI-RADS) descriptors.
Objectives: The study purposes to determine the malignancy risk of microcalcification groups regarding these characteristics and
also compare the 4th and 5th versions of BI-RADS.
Patients and Methods: In a cross sectional study, 88 patients with microcalcification groups (age range, 26 - 80 years; mean, 53.4
years) who had undergone mammographically guided biopsy between March 2013 and March 2015 were evaluated. The overall
number of microcalcification groups in each patient, number of deposits within each group, group location and heterogeneity in
size, density and morphology were assessed and subsequently BI-RADS descriptors for 4th and 5th editions were recorded separately.
Finally, correlation with histopathology was performed.
Results: Overall, positive predictive value (PPV) of suspicious microcalcifications was 22.4%. PPVs of morphology descriptors were as
follows: amorphous, 7.9%; coarse heterogeneous, 17.8%; fine pleomorphic, 63.2%; fine linear/fine linear branching, 100%; (P < 0.001).
Heterogenicity in size existed in 81 cases (92%), in density in 69 cases (86.4%) and in morphology in 86 cases (97.7%). Additionally,
microcalcification groups that were accompanied with soft-tissue density had a higher percentage of malignancy (67.5% vs. 54.5%)
but with no significant difference (P = 0.2). According to BI-RADS 4th edition, the risk of malignancy was 49.1%, 66.7% and 88.1% in
4b, 4c and 5, respectively. These figures were 30%, 82.9%, and 100% for BI-RADS 5th version, respectively. The area under the receiver
(AUC) of 4th and 5th versions of BI-RADS was 0.76 and 0.74 (both P values < 0.001, 95% confidence intervals = 0.66-0.87 and 0.63 -
0.85 respectively). P value for comparison was insignificant.
Conclusion: The risk of malignancy increased with the heterogeneity of microcalcifications, especially in the groups with hetero-
geneity in density, however with no statistically significant difference. BI-RADS 5th edition could predict the likelihood of malig-
nancy as well as 4th version.
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1. Background
Mammographically visible microcalcifications are
present in approximately 55% of non-palpable breast
malignancies (1). They are responsible for detection of 85%
- 95% of the cases of ductal carcinoma in situ (DCIS) by
screening mammography (2). DCIS accounts for 20% - 25%
of breast cancers detected at screening mammography
(3).
The Breast Imaging Reporting and Data System (BI-
RADS) has standardized and facilitated the description and
management of microcalcifications identified on mam-
mograms (4, 5).
Based on BI-RADS 5th edition that was published in
2013, the term of grouped distribution (historically “clus-
tered”) is usually used when five calcifications grouped
within 1 cm of each other or when a definable pattern is
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identified. The upper limit for use of this descriptor is
when larger numbers of calcifications gather within 2cm
of each other (4, 5). The microcalcifications with morphol-
ogy of coarse heterogeneous, fine pleomorphic, fine linear,
fine linear branching and amorphous are suspicious forms
and should further evaluate by biopsy.
In detail, suspicious morphology is defined as follows:
1. Amorphous (BI-RADS 4b; hazy in appearance with no
distinct and sharp border)
2. Coarse heterogeneous (BI-RADS 4b; irregular calci-
fications smaller than dystrophic calcifications measured
between 0.5 mm and 1 mm, they tend to coalesce)
3. Fine pleomorphic (BI-RADS 4c; usually more conspic-
uous than amorphous forms with discrete shapes often
measure < 0.5 mm)
4. Fine linear or fine-linear branching (BI-RADS 4c; thin
and irregular linear calcifications measure usually < 0.5
mm).
In the previous 2003 atlas of BI-RADS (4th edition), the
clusters of microcalcifications were classified by morphol-
ogy and distribution either as benign, intermediate con-
cern or high probability of malignancy; and groups with
fine pleomorphic and linear morphology were categorized
as BI-RADS 5 category. Nevertheless, in the new 2013 ver-
sion, the approach has changed and they were reclassified
as suspicious forms (BI-RADS 4C) (4, 5). Therefore, groups
with coarse heterogeneous and amorphous morphology
are included in 4b category and the fine pleomorphic and
fine linear branching morphologies are in the 4c category.
If any distortion is associated with the latter forms, the fi-
nal BIRADS would be 5 (4, 5).
On the other hand, heterogeneity (in size, morphology
and density) and number of microcalcification within a
group are not included in BI-RADS classification.
2. Objectives
The purpose of this study was to retrospectively deter-
mine the malignancy risk of microcalcification groups re-
garding these characteristics. In addition, we compared
the fourth and fifth editions of BI-RADS in their interpre-
tation.
3. Patients and Methods
In a cross sectional study, 88 patients with microcalci-
fication groups (age range, 26 - 80 years; mean, 53.4 years)
who had undergone mammographically guided biopsy
between March 2013 and March 2015 were evaluated.
All mammographic examinations were obtained by us-
ing a LORAD Selenia (Hologic) full-field digital mammogra-
phy system. Screening and diagnostic mammograms were
obtained prior to mammographically guided biopsy, then
analyzed by a breast subspecialty-trained radiologist.
Overall, the number of microcalcification groups in
each patient, number of deposits within each group, group
location and heterogeneity in size, density and morphol-
ogy assessed and subsequently BI-RADS descriptors for
fourth and fifth editions were recorded separately. Finally,
correlation with histopathology was performed.
3.1. Statistical Analysis
In statistical analysis, the Fisher-Freeman-Halton Exact
Test, the linear association chi-square test and SPSS were
used to evaluate the statistical significance among the de-
scriptor groups with respect to the risk of malignancy.
A statistically significant difference was defined as P
values of less than 0.05 and for results found to be statisti-
cally significant, odds ratios and 95% confidence intervals
(CIs) were used in a pairwise method to assess differences.
Additionally, for assessment of the efficacy of BIRADS
versions we used receiver operating characteristics (ROC)
curves.
4. Results
In this study, 88 patients, who had grouped calcifica-
tions on mammogram and underwent mammo-guided
biopsy, were included. All of them were women with the
mean age of 54.3 years. The malignant groups composed
53 out of 88 (60.2%) cases and were mostly located in the
upper outer quadrants in 30 (34%) cases (Table 1), mostly in
upper parts and further in the left breast in 49 (55.7%) cases.
Table 1. Location of the Calcification Groups
Location No. (%)
Upper/outer 30 (34.1)
Upper/inner 2 (2.3)
Lower/inner 4 (4.5)
Lower/outer 6 (6.8)
Upper 18 (20.5)
Medial 2 (2.3)
Lower 8 (9.1)
Lateral 5 (5.7)
Retroareolar/Central 13 (14.8)
Evaluation of frequency distribution demonstrated
that the most common morphology descriptors included
pleomorphic (27/88, 30.7%) and amorphous (26/88, 29.
5%). The less frequent features were coarse heterogeneous
(19/88, 21.6%) and fine linear and fine linear branching
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(16/88, 18. 2%). In 86.4% of cases, the calcium flecks within
the group were above 10.
Heterogeneity in size was seen in 81 cases (92%) and in
density and morphology it was noted in 69 (78.4%) and 86
cases (97.7%), respectively.
The probability of malignancy based on morphology
is as follows: coarse heterogeneous (Figure 1), 42.1% (8 out
of 19); amorphous (Figure 2), 29% (7 out of 26); fine pleo-
morphic, 85.2% (23 out of 27); and fine linear (Figure 3) and
fine linear branching, 93% (15 out of 16), which showed a
statistically significant difference between these groups (P
< 0.001) (Table 2).
Figure 1. Calcification groups that have amorphous morphology as seen here on
magnification view. They were suspicious, which led to the diagnosis of fibrocystic
changes after histopathological assessment.
As shown in Table 3, the likelihood of malignancy in
groups under 10 in number of microcalcifications were
50% (6 out of 12) and in above 10 group, 61.8% (47 out of 76).
Heterogeneity in size existed in 81 cases (92%), in density, in
69 cases (86.4%) and in morphology, in 86 cases (97.7%).
The risk of malignancy increased with the heterogene-
ity of microcalcifications especially in the groups with het-
erogeneity in density, however with no statistically signifi-
cant difference. (P =0.68). The overall PPV of suspicious mi-
crocalcifications was 22.4%. PPVs of morphology descrip-
tors were as follows: amorphous, 7.9 %; coarse heteroge-
neous, 17.8 %; fine pleomorphic, 63.2 %; fine linear/fine lin-
Figure 2. There are calcifications with fine linear morphology and fine-linear
branching morphology on this magnification view. As we know, they should be
judged by those with the worse morphology. Core biopsy showed invasive ductal
carcinoma.
Table 2. Probability of Malignancy Regarding Morphology of the Calcifications, All
with Grouped Distributiona
Morphology
descriptor
Probability of
malignancy
Positive predictive
value
Amorphous 7/26 (29) 7.9
Coarse
heterogeneous
8/19 (42.1) 17.8
Fine linear or
fine-linear
branching
23/27 (85.2) 63.2
Fine pleomorphic 15/16 (93) 100
aValues are expressed as No.(%)
ear branching, 100 % (P < 0.001).
We assessed the area under the receiver operating char-
acteristic (AUC of ROC) curve for evaluating BIRADS efficacy
in predicting the risk of malignancy, regarding that the
AUC of 4th and 5th versions of BIRADS were 0.76 and 0.74
(both P values < 0.001, 95% confidence intervals = 0.66 -
0.87 and 0.63 - 0.85 respectively). P value for comparison
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Table 3. Diagnostic Efficacies of Different Descriptors for Malignancy
Variable TP FN TN FP Sen %95CI Spec %95CI PPV %95CI NPV %95CI PLR %95CI NLR %95CI Accuracy
%95CI
Number (<10and >10) 47 6 6 30 0.89
(0.77-0.96)
0.17
(0.06-0.33)
0.61
(0.49-0.72)
0.5
(0.21-0.79)
1.1 (0.89-1.3) 1.47 (0.5-4.1) 0.6
(0.49-0.7)
Size heterogeneity 51 2 6 30 0.96
(0.87-0.99)
0.17
(0.06-0.33)
0.63
(0.52-0.73)
0.75
(0.35-0.17)
1.2 (0.99-1.3) 4.4
(0.94-20.7)
0.64
(0.53-0.74)
Density
heterogeneity
45 8 12 24 0.85
(0.72-0.93)
0.33
(0.19-0.51)
0.65
(0.53-0.76)
0.6
(0.36-0.81)
1.3 (0.98-1.6) 2.2 (1-4.9) 0.63
(0.5-0.74)
Morphology
heterogeneity
53 0 2 34 1 (0.93-1) 0.06
(0.01-0.19)
0.61
(0.5-0.71)
1 (0.16-1) 1.1 (0.98-1.1) - 0.62
(0.51-0.72)
Distribution (1 vs. >1) 13 40 28 8 0.25
(0.14-0.38)
0.78
(0.61-0.9)
0.62
(0.38-0.82)
0.41
(0.29-0.54)
1.1 (0.51-2.4) 1.3 (0.82-1.3) 0.46
(0.35-0.57)
Associated (yes vs. no) 27 26 23 13 0.51
(0.37-0.65)
0.64
(0.46-0.79)
0.68
(0.51-0.81)
0.47
(0.33-0.62)
1.4 (0.85-2.3) 1.3 (0.9-1.9) 0.56
(0.45-0.67)
Abbreviations: CI, confidence interval; FN, false negative; FP, false positive; NLR, negative likelihood ratio; NPV, negative predictive value; PLR, positive likelihood ratio;
PPV, positive predictive value; Sen, sensitivity; spec, specificity; TN, true negative; TP, true positive.
Figure 3. In this mammogram, groups of coarse heterogeneous morphology with
tissue distortion are due to invasive ductal carcinoma.
of two BIRADS was insignificant. Considering successive
cutoff points [(4a - 4b), (4b - 4c) and (4 - 5)] for BIRADS ver-
sions, diagnostic efficacies of two BIRADS versions were cal-
culated (Table 4).
5. Discussion
Calcium deposits are extremely common in mammo-
grams which increase with age between the ranges of 8 to
86% (6).
As previous studies reported, small calcium groupings
are one of the frequent features of breast cancer on mam-
mograms (7). In this study, most of the calcium groups
were histologically malignant and located in the left upper
and upper outer quadrants. The pleomorphic and amor-
phous morphologies are the most common forms. Cal-
cium flecks within the group were above 10 in most groups.
Mammographic assessment of microcalcifications
and classification according to BI-RADS system is an
essential part of abnormal screening or diagnostic mam-
mograms. Regarding the last edition of BI-RADS system,
when they are visible in a volume of approximately 2 cm3
with a numerical threshold of five or more calcium flecks,
20% to 25% of them may indicate cancer.
The risk of malignancy accompanied with a mammo-
graphic microcalcification in our study is comparable to
results done by most investigators with the range of 13%
- 36% (8-10). Our data showed that the positive predictive
value for microcalcification group risk of malignancy is
22.4%.
The most important element of microcalcification
characteristics is morphology. The shape of calcium flecks
and heterogeneity of them in shape are valuable in deter-
mining the likelihood of malignancy and suspicion should
be aroused as previously reported in prior studies (11).
The microcalcification morphologic descriptors amor-
phous, coarse heterogeneous, fine pleomorphic, and fine
linear had a progressively increasing risk of malignancy
especially the fine linear and fine linear branching types
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Table 4. Diagnostic Efficacies of Two BI-RADS Lexicons in Different Cutoff Points
BI-RADS
Version
Cutt-Off
Point
TP FN TN FP Sen
[95%CI]
Spec
[95%CI]
PPV
[95%CI]
NPV
[95%CI]
PLR
[95%CI]
NLR
[95%CI]
Accuracy
[95%CI]
4th
4a versus
others
58 1 5 24 98 [91-99] 17 [6-36] 71 [60-80] 83 [36-99] 1.2 [1-1.4] 10.2 [1.2-83] 72 [61-81]
(4a and 4b)
versus others
41 18 22 7 69 [56-81] 76 [56-90] 85 [72-94] 55 [38-71] 2.9 [1.5-5.6] 2.5 [1.6-3.8] 72 [61-81]
4 versus 5 37 22 24 5 63 [49-75] 83 [64-94] 88 [74-96] 52 [37-67] 3.6 [1.6-8.3] 2.2 [1.5-3.2] 69 [59-79]
5th
4b versus
others
41 18 22 7 69 [56-81] 76 [56-90] 85 [72-94] 55 [38-71] 2.9 [1.5-5.6] 2.5 [1.6-3.8] 72 [61-81]
4 versus 5 7 52 29 0 12 [5-23] 100
[88-100]
100
[59-100]
36 [25-47] - 1.1 [1-1.2] 41 [31-52]
Abbreviations: BI-RADS, breast imaging reporting and data system; CI, confidence interval; FN, false negative; FP, false positive; NLR, negative likelihood ratio; NPV,
negative predictive value; PLR, positive likelihood ratio; PPV, positive predictive value; Sen, sensitivity; spec, specificity; TN, true negative; TP, true positive.
with estimated percentages of 29%, 42%, 85% and 93%, re-
spectively.
The positive predictive value of malignancy likelihood
for fine pleomorphic and fine linear/fine linear branching
are higher than previous similar studies (4-12).
It can be mentioned that in the case of coarse hetero-
geneous morphology, the risk of malignancy is compatible
with prior data; although relatively few studies have been
carried out before (12).
Additionally, the risk of malignancy of amorphous
morphology (7.9%) shows lower PPV compared to prior
studies; however, regarding BI-RADS system, this morphol-
ogy descriptor with about eight percent of malignancy is
within the 4b category (higher than 2%).
Pathologically, the overall heterogeneity and number
of calcium deposits could be due to the process of tumor
necrosis. Therefore, in our experience and that of others, ir-
regular heterogeneous groups with an increased number
of calcium flecks are more suspicious for malignancy rea-
sonably as Egan et al. concluded in a study and found sim-
ilar results.
Heterogeneity in size, density and morphology of mi-
croclacifiaction groups as well as increasing numbers of
calcium deposits within a group increased the likelihood
of malignancy with CI of 1, 0.96, 0.89 and 0.85, respectively.
In this study, group microcalcifications in association
with an asymmetry, ill-defined density or tissue distortion
are of more concern and increased risk of malignancy,
which is consistent with previous studies (13).
Apparently, BI-RADS category 5 is usually reserved for
lesions having a 95% probability of malignancy. If a mam-
mogram is classified into BI-RADS category 4 or 5 it tends to
have a positive predictive value of breast cancer of approx-
imately 2% or more.
The frequency of carcinoma was higher in category 5
than in category 4 lesions, which is similar to previously
reported findings (4, 5).
In conclusion, in this study we found that the descrip-
tors in BI-RADS 5th edition could predict the risk of malig-
nancy as well as 4th edition with no significant statistical
difference although comparing PPV of descriptors, the like-
lihood of malignancy is slightly closer to the 5th edition
predictors than the 4th.
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